Introduction
============

Relapsing fever (RF) is an infectious disease with a sudden onset of high fever; it is caused by several species of bacteria belonging to the genus *Borrelia* and, as its name indicates, is characterized by the occurrence of one or more spells of fever after the subsidence of the primary febrile attack ([@b5-ijad-5-7]). The presence of massive amounts of spirochetes during fever peaks makes diagnosis of the infection an easy practice with dark-field microscopy or Giemsa staining method ([@b1-ijad-5-7]). However, between the peaks and in milder infections these methods are often negative due to a low number of bacteria in blood stream, making the infection under diagnosed. PCR assays that target different genes including 16S ribosomal RNA (*rrs*), Flag-ellin (*flaB*), and Glycerophosphodiester phosphodiesterase (*GlpQ*) were successfully used for detection of spirochetes in blood and *Ornithodoros* tick vectors ([@b14-ijad-5-7], [@b2-ijad-5-7], [@b7-ijad-5-7], [@b12-ijad-5-7], [@b3-ijad-5-7]). Species-specific PCR and RCR-RFLP method were also developed for diagnosis of some *Borrelia* species ([@b1-ijad-5-7], [@b3-ijad-5-7]). However, the method is costly, labor intensive and requires well-equipped laboratories. The ELISA based on product of GlpQ gene can discriminate between RF and Lyme borreliosis but cannot differentiate between an active and past RF infection ([@b15-ijad-5-7]). Quantitative buffy coat (QBC) analysis of blood samples showed to be a reliable for diagnosis of RF when the spirochetes are low in numbers, but it relies on florescent microscopy, the equipment rarely available in rural health centers ([@b16-ijad-5-7], [@b6-ijad-5-7]). Recently, a novel centrifugation-based method with minimal laboratory requirements showed very promising, detecting concentrations less than 10 bacteria/ml blood ([@b10-ijad-5-7]). In this study we compare the sensitivity of several PCR assays that amplify DNA sequences of three different loci including *rrs*, *fla*B, and *GlpQ* with the centrifugation-based enrichment method and Giemsa staining to detect bacteria in animal blood samples.

Materials and Methods
=====================

Borrelia
--------

*Borrelia persica* was isolated from *Ornithodoros tholozani* ticks, collected from Ardebil Province, and maintained in guinea pigs through serial passages for seven successive years.

Blood samples
-------------

Adult guinea pigs were inoculated intraperitoneally with 0.5 ml of *B. persica* infected blood preserved in −70° C with 50% glycerol. From day three, daily amount of 500--600μl of blood was taken from animals' heart using insulin syringes and bacteria count was determined using dark-field microscopy. Blood collection continued for eight days, until no spirochete was detectable in the blood samples with dark-field microscopy. The intensity of infection in blood samples was obtained by counting the spirochetes using a Neubauer haemocytometer. When animals were negative for two successive days (days nine and ten) large amounts of blood was collected from their hearts and amounts of 10 ml were examined for presence of spirochetes using centrifuged-based enrichment method. Also, Buffy Coat Layer (BCL) was obtained from 3 ml of the same blood samples using the lymphocyte®-H kit (Cedarlane, Netherland). We also prepared fifteen serial dilutions from an infected guinea pig blood sample containing 25×10^4^ spirochetes/ml blood, with sodium citrate-anticoagulated blood from healthy individuals ([Table 3](#t3-ijad-5-7){ref-type="table"}). Giemsa-stained thin and thick smears were prepared in triplicate from all dilutions and the rest of blood samples were examined for presence of spirochetes using centrifuged-based enrichment method.

Centrifuged-based enrichment method
-----------------------------------

The method basically comprised two centrifugation steps; the blood samples were first centrifuged at 500 × g for 5 min, the plasma were recovered to new tubes and second centrifugation was performed at 5000 × g for 10 min. The supernatants were decanted, and the pellets were resuspended in the few remaining microliters of plasma. The suspensions were smeared onto a glass slides and air dried for 10 min. The smears were fixed by heating over a flame followed by a 30 s dip in methanol. The slides were stained with Giemsa and examined for recovered spirochetes at 1000X magnification.

DNA extraction method and PCR
-----------------------------

Amounts of 200μl of blood samples and 500 μl of buffy coats were subjected to DNA extraction, using the Miniprep DNA extraction Kit (Kiagen, Germany) according to manufacturer's recommendations.

Detection of *B. persica* by PCR was performed through amplification of three different genes including *rrs, flaB, and GlpQ*. The *fla*B and *GlpQ* genes were amplified using the primers and thermocycler programs outlined by other authors ([@b2-ijad-5-7], [@b7-ijad-5-7]). The 25μl reactions contained 20 pmol of each primer, 1.7mM MgCl~2~, 10mM Tris-HCl, 50 mM KCl, 200M of dNTPs, 1U of *Taq* and 3μl of DNA. Amplification of *rrs* was performed using the nested PCR technique as described previously ([@b4-ijad-5-7], [@b12-ijad-5-7]). The list of primers, target genes, and expected band sizes are reflected in [Table 1](#t1-ijad-5-7){ref-type="table"}.

Results
=======

PCR
---

The *GlpQ*-PCR did not yield the expected 212bp band with low sprirochetemia blood samples i.e. those that were negative with dark-field microscopy ([Table 1](#t1-ijad-5-7){ref-type="table"}, Days 9 and 10). However, the DNA from BCL of the same blood samples was successfully amplified using the same reagents and PCR conditions. The *fla*B-PCR and nested *rrs*-PCR were positive with various degrees of spirochetemia including those that were negative by dark-field microscopy. The details of PCR assays are shown in [Table 2](#t2-ijad-5-7){ref-type="table"}.

Centrifugation-based enrichment method
--------------------------------------

Centrifugation-based enrichment recovered 890 and 357 spirochetes form two 10 ml of blood samples that were negative with dark-field microscopy examination ([Table 2](#t2-ijad-5-7){ref-type="table"}). We could recover 25 spirochetes on the glass slides by microscopy when as low as about 250 bacteria (a concentration equivalent to 50 bacteria/ml) were spiked into 5ml blood samples. No spirochete was recovered with concentration below 25 bacteria in ml of blood ([Table 3](#t3-ijad-5-7){ref-type="table"}).

Geimsa-stained smears analysis
------------------------------

Geimsa-stained thin smears were consistently positive with samples containing ≥10^5^ spirochetes/ml blood, but only two of the three smears at concentrations 6.26×10^4^ spirochetes/ml and one of three smears at concentrations 5×10^4^ spirochetes/ml were positive. The Giemsa-stained thick smears were all positive at ≥ 5×10^4^ spirochetes/ml, but only two of the three smears at concentrations 4×10^4^ and 3×10^3^ spirochetes/ml, and one of the three smears at concentration 25×10^3^ spirochetes/ml were positive ([Table 2](#t2-ijad-5-7){ref-type="table"}).

Discussion
==========

Tick-borne Relapsing fever (TBRF) is one of the prevalent bacterial diseases in different parts of the world ([@b8-ijad-5-7], [@b3-ijad-5-7]). The disease in Iran is caused primarily by *Borrelia persica*, which is transmitted by *Ornithodoros tholozani* ticks. Other *Borrelia* species including *B. microtii*, *B. latyschevii*, and *B. baltazardi* have also been reported from Iran ([@b9-ijad-5-7], [@b8-ijad-5-7]). From 1997 to 2006, a total of cases 1415 were reported from the entire country, some from areas out of *O. tholozani* distribution includ hormozgan and Fars Provinces ([@b11-ijad-5-7]). Most of the RF cases in Hormozgan Province were detected during attempts for diagnosis of malaria parasite in Giemsa-stained blood smears from febrile patients. Since, thick smears commonly turn positive during fever peaks that are associated with massive spirochetemia; it is posssible that a large number of RF cases that refer to hospitals and health care centers during non-febrile periods remain underdiagnosed. The inabilities of microscopic analysis to detect spirochetes in blood have been demonstrated by some authors ([@b2-ijad-5-7], [@b7-ijad-5-7], [@b12-ijad-5-7]). PCR-based diagnosis offered a new approach to this problem. Our results showed that the *flaB*-PCR could detect *Borrelia* flagellin DNA in blood samples with low grade bacteremia that are commonly negative by dark-field microscopy ([Table 2](#t2-ijad-5-7){ref-type="table"}). The nested *rrs*-PCR also showed very sensitive and was positive with various degrees of bacteremia ([Table 2](#t2-ijad-5-7){ref-type="table"}); however it was very vulnerable to cross-contamination and led to false positive results when positive controls were included in assays. Dilution of first round products with distilled water with 1:10 ratio reduced the false positivity results by 90%. The *GlpQ*-PCR was not positive with low grade spirochetemia blood samples i.e. those that turned negative by dark-field microscopy. However, the DNA from BCL of the same blood samples yielded the expected band with the same PCR protocol ([Table 2](#t2-ijad-5-7){ref-type="table"}). Accumulation of spirochetes in BCL was already documented by other authors ([@b16-ijad-5-7], [@b6-ijad-5-7]). Thus, extraction of DNA from BCL increases the chance of detecting infection with PCR, particularly during non febrile periods. We could recover 870 and 357 spirochetes by centrifuged--based enrichment method from two 10 ml of guinea pig blood samples that were negative by dark-field microscopy and *GlpQ*-PCR. In our study, the sensitivity of the centrifuged--based enrichment method improved as number of spirochetes spiked into the blood samples decreased; the highest ratio (recovered/spiked into) was obtained with 250 spirochetes/5ml of blood ([Table 3](#t3-ijad-5-7){ref-type="table"}). Since the sensitivity of thick smears, the routine method for detection of RF agents, was around 25000 spirochetes in ml of blood ([Table 2](#t2-ijad-5-7){ref-type="table"}), the centrifuged--based enrichment method could be as much as 500 times more sensitive than thick smear analysis. In conclusion, PCR particularly when DNA is extracted from BCL is a useful tool for diagnosis of RF cases that cannot be diagnoses by microscopic analysis. However, the method is commonly available in big hospitals and well-equipped laboratories. Centrifuged based enrichment method showed a high sensitivity and even appeared to be superior to *GlpQ*-PCR. Regarding the fact that it requires the equipments that are commonly available in small laboratories, this method is more feasible for RF diagnostics in underprivileged rural health centers.
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###### 

List of primers used in this study

  ------------------------------------------------------------------------------------------
  **Primer**   **Sequence (5′ to 3′)**   **Target gene**   **Expected band size**   
  ------------ ------------------------- ----------------- ------------------------ --------
  128F         cag aac ata cct\          *GlpQ*                                     212 bp
               tag aag ctc aag c                                                    

  340r         gtg att tga ttt\                                                     
               ctg cta atg tg                                                       

  BOR1         taa tac gtc agc\          *flaB*                                     750 bp
               cat aaa tgc                                                          

  BOR2         gct ctt tga tca\                                                     
               gttatc att c                                                         

  Fd3          aga gtt tga tcc\          *rrs*             1^st^ round              613 bp
               tgg ctt ag                                                           

  595R         ctt gca tat ccg\                                                     
               cct act ca                                                           

  Fd4          ggc tta gaa cta\          2^nd^ round       527 bp                   
               acg ctg gca g                                                        

  500R         ctg ctg gca cgt\                                                     
               aat tag cc                                                           
  ------------------------------------------------------------------------------------------

###### 

Details of blood samples and other blood products used for PCR assays

  **Samples**   **Days after inoculation**   **Dark field microscopy**   **Spirochetes in μl of blood**   **Type and amount of sample**   ***GLPQ* PCR**   ***flaB* PCR**   **Nested *rrs*PCR**   **Spirochetes recovered by CEM**
  ------------- ---------------------------- --------------------------- -------------------------------- ------------------------------- ---------------- ---------------- --------------------- ----------------------------------
  1             3                            10p *f*                     2750                             Blood/200 μl                    \+               \+               \+                    NP
  2             4                            20p *f*                     6750                             Blood/200 μl                    \+               \+               \+                    NP
  3             5                            1p5 *f*                     375                              Blood/200 μl                    \+               \+               \+                    NP
  4             6                            1p *f*                      1500                             Blood/200 μl                    \+               \+               \+                    NP
  5             7                            1p10 *f*                    250                              Blood/200 μl                    \+               \+               \+                    NP
  6             8                            1p5*f*                      250                              Blood/200 μl                    \+               \+               \+                    NP
  7             9                            Neg.                        Not seen                         Blood/200 μl                    Neg.             \+               \+                    NP
  8             10                           Neg.                        Not seen                         Blood/200 μl                    Neg.             \+               \+                    870 and 375
  9             9                            Neg.                        Not seen                         BCL/500 μl                      \+               NP               NP                    NP
  10            10                           Neg.                        Not seen                         BCL/500 μl                      \+               NP               NP                    NP

BCL = Buffy Coat Layer, NP = Not Performed, CBE = Centrifuged-based Enrichment Method

10p*f* =10 spirochetes in one microscopic field, 20p*f*= 20 spirochetes in one microscopic field, 1p5*f*= 1spirochete in 5 microscopic fields, 1p*f*= 1 spirochetes in one microscopic field, 1p10*f*=1spirochete in 10 microscopic fields, Neg.= negative, no spirochetes was seen in 30 microscopic fields.

###### 

Details of blood samples used for Giemsa-stain analysis and centrifuged-based enrichment method

  **Sample code**   **Amounts of blood (ml)**   **Number of bacteria spiked into**   **Giemsa-stained thin smears**   **Giemsa-stained thick smears**   **Number of Recovered bacteria**   **Ratio of spirochetes (Recovered/spiked into)**
  ----------------- --------------------------- ------------------------------------ -------------------------------- --------------------------------- ---------------------------------- --------------------------------------------------
  1                 5.00                        250000                               \+ + +                           \+ + +                            NP                                 NA
  2                 5.00                        150000                               \+ + +                           \+ + +                            NP                                 NA
  3                 6.00                        125000                               \+ + +                           \+ + +                            970                                1/128
  4                 5.00                        100000                               \+ + +                           \+ + +                            NP                                 NA
  5                 5.00                        62500                                \+ + −                           \+ + +                            NP                                 NA
  6                 5.00                        50000                                \+ − −                           \+ + +                            NP                                 NA
  7                 5.00                        40000                                − − −                            \+ + −                            NP                                 NA
  8                 5.00                        30000                                − − −                            \+ + −                            NP                                 NA
  9                 5.20                        25000                                − − −                            \+ − −                            255                                1/98
  10                5.00                        20000                                − − −                            − − −                             NP                                 NA
  11                5.10                        12500                                − − −                            − − −                             132                                1/94
  12                5.00                        6250                                 − − −                            − − −                             52                                 1/120
  13                5.00                        1250                                 − − −                            − − −                             31                                 1/40
  14                5.00                        625                                  − − −                            − − −                             25                                 1/25
  15                5.00                        250                                  − − −                            − − −                             25                                 1/10
  16                5.00                        125                                  − − −                            − − −                             0                                  0

NP= Not performed, NA= Non applicable
